The Myriad Genetics case examines whether isolated gene sequences are patentable or considered products of nature under US law. The Supreme Court ruled that while gDNA is not patentable, cDNA may be, marking a significant development in genetic patentability.
Read more about Myriad Genetics Case : Genetic PatentabilityTag: BRCA2
The Gene Returns to its Body
Judge Sweet’s landmark ruling held that isolated gene sequences and their analysis are not patentable under US law. This decision invalidated key BRCA gene patents and marks a significant shift in the legal approach to biotechnology patents in the United States.
Read more about The Gene Returns to its Body